Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2026 Jan 31:2026.01.30.702828. [Version 1] doi: 10.64898/2026.01.30.702828

Alpha oscillations are dysrhythmic in Fragile X syndrome

Peyton Siekierski 1,2,*, Yanchen Liu 1, Grace Westerkamp 1, Rana Elmaghraby 1,6, Zag ElSayed 3, Donald Gilbert 4,5, Craig A Erickson 1,6, Ernest V Pedapati 1,5,6
PMCID: PMC12874049  PMID: 41659484

Abstract

Background:

Alpha oscillations are dominant rhythms in the human brain, supporting inhibitory control and coordination of neural activity. Altered alpha dynamics are observed across many neuropsychiatric and neurodevelopmental disorders, including Fragile X syndrome (FXS), the most common monogenic cause of autism and intellectual disability. FXS exhibits paradoxical alpha power: elevated absolute but reduced relative power. To resolve this incongruity, we considered that conventional power metrics, relying on averaging, may obscure the underlying critical temporal dynamics of such neural rhythms.

Methods:

Here, we investigate alpha oscillations in FXS as a model to decompose nonspecific alpha abnormalities into underlying temporal features. We used cycle-by-cycle (bycycle) alpha burst analysis from source-localized resting-state EEG of 70 individuals with FXS (20.5±10.0 years; 32 females, 38 males) and 71 age- and sex-matched typically developing controls (22.2±10.7 years; 30 females, 41 males). Statistical modeling examined group, sex, and regional differences in alpha burst features using generalized linear mixed-effects models.

Results:

We reveal that alpha bursts in FXS show reduced count only in males, prolonged periods across sexes, and elevated amplitudes, particularly in males. Spatial mapping identified differential circuit vulnerability: timing-associated dysregulation in cognitive-control regions and amplitude elevations in sensory cortices. Within the FXS group, global alpha burst amplitude correlated with hyperactivity symptoms and inversely with general intelligence scores, and burst count correlated with age.

Limitations:

This study is limited by its resting-state design and cross-sectional nature. Future studies should explore task-based modulation of alpha burst features and longitudinal trajectories in FXS. Additionally, fragile X messenger ribonucleoprotein (FMRP) was not quantified for participants, limiting potential stratification by molecular severity.

Conclusions:

These findings resolve paradoxical alpha power in FXS into features consistent with interneuron dysfunction, demonstrating the potential for burst-level decomposition in mechanistic hypothesis generation and biomarker development across neurodevelopmental and neuropsychiatric disorders.

Keywords: Alpha oscillations, electroencephalography, Fragile X syndrome, waveform analysis, neurodevelopmental disorders, resting-state

Introduction

Alpha oscillations (8–12.5 Hz) are a prominent and functionally significant oscillation in the human brain and have been implicated as a mechanism for inhibitory control and timing of neural activity1, 2. Alpha oscillation generation and propagation is complex and incompletely understood, with the prevailing view implicating thalamocortical and cortico-cortical circuits, suggesting that alpha dysfunction may manifest differently across brain regions3–7. Alterations in alpha oscillations are common across clinical populations and reflect a shared transdiagnostic vulnerability. Peak alpha frequency (PAF) is diminished in autism spectrum disorder (ASD), psychotic disorders, and Parkinson’s disease8–10. Alpha disruptions linked with changes in high-frequency activity (termed thalamocortical dysrhythmia) have been identified in epilepsy, schizophrenia, and major depressive disorder11–15. Fragile X syndrome (FXS) exemplifies this motif, exhibiting reduced relative alpha power, slowed alpha frequency, increased gamma power, and abnormal theta–gamma coupling16–19. Notably, reduced relative alpha power in FXS correlates with symptom severity, including increased anxiety, decreased auditory attention, and impaired social functioning16. FXS offers a genetically defined model to study changes in alpha activity which may reflect compromised network coordination and timing20.

FXS provides an ideal model to dissect alpha dysfunction mechanisms, as the most common monogenic cause of intellectual disability and autism. This disorder is caused by the silencing of the FMR1 gene, leading to loss of fragile X messenger ribonucleoprotein (FMRP). FMRP is a key regulator of dendritic maturation, synaptic protein synthesis, and experience-dependent circuit refinement21–24. X-linked inheritance results in high clinical penetrance and typically greater phenotypic severity in males due to near-complete FMRP absence, whereas affected females are obligate mosaics with variable FMRP expression due to random X-inactivation. Individuals affected by FXS manifest impairments in cognition, language, and social interactions, leading to lifelong disability25. Thus far, pharmacological interventions that have shown efficacy in Fmr1 knockout (KO) mouse models have largely failed to translate to meaningful clinical benefits in humans26–28. This gap reflects our limited understanding of how FMRP loss uniquely disrupts neural function in humans and a misalignment with translational biomarkers, which represent a key obstacle to therapeutic progress in FXS29. Alpha oscillations represent a prime candidate to explain the discrepancy between humans and rodent models: in human FXS, these rhythms show alterations that correlate with clinical measures16, 30, yet they remain poorly characterized in Fmr1 KO mouse models31–33.

Interestingly, power spectrum analysis of the alpha band in FXS has paradoxically found reduced relative alpha power yet largely elevated absolute alpha power16 (Fig. 1). We can reconcile this contradiction methodologically as conventional Fourier-based approaches time-average neural activity and thus overlook the dynamic, burst-like nature of neural oscillations34, 35. Furthermore, these approaches obscure raw waveform features that may provide deeper insight into the underlying substrate which generate coherent rhythmic field potentials from vast neuronal populations36. Cycle-by-cycle analysis (“bycycle”) represents a methodological advancement that preserves the time-related structure of neural oscillations while extracting detailed waveform characteristics for individual oscillatory cycles37. This approach enables quantification of alpha burst detection, amplitude modulation, and period variability in the time domain, providing a more nuanced window into compound alpha oscillatory dysfunction. Cycle-by-cycle analysis complements other time-resolved approaches such as empirical mode decomposition and burst detection algorithms used to characterize transient oscillations in movement disorders and attention paradigms38, 39.

Fig. 1. Decreased relative and increased absolute alpha power in FXS.

Fig. 1.

(a–b) Scalp EEG power spectra for males and females with FXS and age- and sex-matched controls demonstrate a paradox between relative and absolute power. (a) Group-averaged relative power spectra (solid lines ± 95% CI) show reduced alpha-band power (8–12.5 Hz) and a leftward shift of the dominant peak frequency in FXS. (b) In contrast, absolute power spectra reveal elevated alpha and broadband power in FXS groups. Insets highlight high-frequency (30–90 Hz) gamma activity. (c) Significant correlations between alpha power and clinical measures across FXS participants and a subgroup of full-mutation (FM) males. Scatterplots show subject-level bivariate and age-corrected partial Spearman correlations, illustrating associations between alpha power and anxiety severity, auditory attention, and social functioning. (d–e) Source-level group contrasts (FXS – Control) illustrate the spatial distribution of these effects, with widespread decreases in relative alpha power (d) and corresponding increases in absolute alpha power (e). Warmer colors indicate FXS > control, cooler colors FXS < control (non-significant vertices shown in gray). Adapted from Pedapati et al., 2022 (Fig. 2b–d, 5d, Supplementary Fig. 2), which reported the original spectral analyses of this same dataset; panels were reformatted for presentation. Licensed under Creative Commons Attribution 4.0 International License.

This study leverages a well-powered previously published resting-state EEG dataset16 to conduct a comprehensive cycle-by-cycle analysis of alpha oscillations in FXS. We conducted our analysis following EEG source localization40 to characterize distribution of alpha burst disruptions across space and time. We hypothesized that individuals with FXS would exhibit specific alterations in burst features consistent with their paradoxical power findings: reduced burst occurrence (potentially explaining reduced relative power), prolonged cycle periods (consistent with frequency slowing), and increased burst amplitude (potentially explaining elevated absolute power). Additionally, we anticipated sex-specific patterns given FMRP expression differences between males and females with FXS. These considerations implicate aberrant alpha dynamics as a key feature of FXS pathophysiology and highlight the need for time domain-associated approaches to reveal their underlying mechanisms.

Methods and Materials

Sample

Resting-state EEG recordings from a previously published dataset from our laboratory16, comprised of individuals with FXS (n=70, 32 females and 38 males; 20.5±10.0 years) and age- and sex-matched TDC (n=71, 30 females and 41 males; 22.2±10.7 years) (National Institutes of Mental Health U54 HD082008). All participants provided written informed consent (or assent, where applicable), and the study was approved by the institutional review board of Cincinnati Children’s Hospital Medical Center. Clinical characteristics of each cohort are presented in Table 1. TDC participants with any neuropsychiatric condition or current medication use were excluded. FXS participants were excluded if there were taking benzodiazepines and/or antiepileptics. FXS participants taking antidepressants, atypical antipsychotics, or other concurrent medications were included, provided they had been on a stable dose for at least six weeks prior to enrollment. This approach reflects typical medication use patterns observed in individuals with FXS.

Table 1.

Demographics and clinical variables

Characteristic FXS, N = 701 TDC, N = 711 p-value2
Sex
 F 32 (46%) 30 (42%)
 M 38 (54%) 41 (58%)
Age at Visit 20.5±10.0 22.2±10.7 0.35
FSIQ 49.5±30.0 103.2±9.2 <0.001
NVIQ 40.0±35.7 103.4±10.7 <0.001
VIQ 58.9±28.7 103.1±12.8 <0.001
SCQ 13.6±7.7 2.1±2.2 <0.001
WJ-III 67.8±15.6 93.5±12.0 <0.001
ADAMS-Depressed 3.6±4.6 1.4±3.1 <0.001
ADAMS-Social 6.6±5.3 1.3±2.6 <0.001
ADAMS-Anxiety 7.2±5.0 2.1±2.5 <0.001
ADAMS-OCD 2.3±2.5 0.4±1.1 <0.001
ABC FXS subscale 4: Hyperactivity/noncompliance 9.0±7.5 0.8±1.7 <0.001
ABC FXS subscale 5: Inappropriate speech 4.5±3.5 0.1±0.5 <0.001
1

n (%); Mean±SD

2

independent Student t tests, p unadjusted significance

FXS Fragile X Syndrome, F female, M male, FSIQ Full Scale IQ, NVIQ Non-verbal intelligence scale, VIQ verbal intelligence scale, SCQ Social Communication Questionnaire, WJ-III Woodcock III Tests of Cognitive Abilities, ADAMS Anxiety, Depression, and Mood Scale, ABC Aberrant Behavior Checklist

Data acquisition and preprocessing

EEG data were collected at a 1000 Hz sampling rate using a 128-channel HydroCel electrode net and EGI NetAmp 400 (Magstim/EGI, Eugene, OR). Continuous EEG data were collected for 5 minutes during resting-state conditions with participants seated comfortably while watching a silent video to encourage cooperation. All EEG data were blinded for preprocessing and analysis. Data was exported in EGI raw format and imported into EEGLAB SET format in MATLAB (version 2018b, The MathWorks Inc., Natick, MA, USA). Raw recordings were high pass digital zero-phase filtered at 2 Hz and notch filtered at 55–65 Hz to remove line noise using EEGLAB 14.1.241. Filtered data were visually inspected to remove noisy channels and segments of data. Removed channels (less than 5% per subject) were interpolated using spherical spline interpolation. Independent component analysis (ICA) decomposition was performed using the extended INFOMAX algorithm in EEGLAB and myogenic contamination was reduced42, 43. The resulting components corresponding to eye, muscle, and channel artifacts were manually identified and removed. Data were average referenced, down sampled to 500 Hz, and divided into 2-second epochs. To ensure consistent data length across participants for comparative analysis, all recordings were normalized to the shortest recording duration identified across the sample (86 seconds). This approach ensured equal data contributions from each participant.

Source estimation

Cycle-by-cycle analysis was performed on source-localized time series. For each subject, 86 seconds of artifact-free data from each of the EGI 128-channel electrodes were co-registered with Montreal Neurological Institute (MNI) averaged ICBM152 common brain template44. Source localization was performed on blinded artifact-free preprocessed data using a weighted minimum norm estimate (MNE) model to generate a current source density map (units: picoampere-meter; pA-m) in Brainstorm45. OpenMEEG was used to compute a 15,000 vertices lead-field mesh incorporating electrode distances46. Individual vertices from the lead-field mesh were grouped into 68 cortical nodes according to the Desikan-Killiany (DK) atlas47 (Supplementary Fig. 1). The anatomical configuration derived from the DK atlas consisted of categorizing the 68 nodes into 14 regions: prefrontal, frontal, central, temporal, parietal, cingulate, and occipital brain regions with bilateral hemisphere (right (R) or left (L)) representation.

Burst parameter optimization and burst identification

Oscillatory burst detection was performed using the bycycle algorithm, which analyzes neural signals cycle by cycle to identify features of sustained rhythmic activity in the time domain. This method can effectively characterize the individual oscillatory cycles in non-averaged, filtered data37 (https://github.com/bycycle-tools/bycycle). Analysis focused on the alpha frequency band (8–12.5 Hz). Bursts consist of a sequence of cycles defined by a set of detection parameters. Excluding the monotonicity parameter, the standard burst detection thresholds were applied to all subjects: (1) amplitude fraction of 0.3, (2) amplitude consistency of 0.4, (3) period consistency of 0.5, (4) minimum cycle requirement of 337. The monotonicity threshold was specifically optimized for alpha separately to allow for detection of more bursts while maintaining shape constraints for genuine oscillatory activity (Supplementary Fig. 2). Monotonicity threshold of 0.55 was used for alpha. Narrowband filtering parameters included 0.5-second filter windows with automatic cycle determination for the alpha frequency range. Burst detection utilized the ‘trough’ as the center extrema reference point, with cycle boundaries defined from trough-to-trough intervals. The standard ‘cycles’ burst method was employed to identify sustained periods of oscillatory activity meeting the specified amplitude, consistency, and shape criteria37.

Bycycle feature generation

For each detected cycle, the bycycle algorithm computed comprehensive waveform characteristics including period, amplitude, and burst count. Period refers to the duration of individual cycles (trough-to-trough intervals). Extracted period values were stored in samples and converted to milliseconds (ms) by dividing by the sampling rate (500 Hz), such that each sample represents 2 milliseconds (1 sample = 2 ms). Amplitude is defined by the peak-to-trough amplitude within each cycle. Burst count is calculated by summing the binary indicator (is_burst) that determines whether each cycle met burst criteria defined above across each normalized recording duration of concatenated epochs.

Statistical modeling

Generalized linear mixed-effects models (GLMMs) were conducted to account for the hierarchical structure of nodes nested within participants. Models were implemented using the glmmTMB package in R, with appropriate distribution families selected based on the nature of dependent variables (Gaussian for continuous features, Poisson for count data). For each feature, models were built using a forward stepwise approach, beginning with a base model containing only group effects and progressively adding complexity. Note that for burst period, statistical models were fitted using period values in samples, and model estimates were converted to milliseconds for reporting. For burst amplitude, values were log10-transformed (base-10 logarithm) for statistical modeling to normalize the distribution. The modeling process started with group as the sole fixed effect, then sequentially evaluated the addition of sex, region, and their interactions (group × sex, group × region, etc.), retaining terms only when they produced statistically significant improvements to model fit. This iterative approach continued until no further significant effects or interactions could be identified, resulting in the final model specifications (Supplementary Table 1). The final models varied in complexity depending on the specific feature analyzed, ranging from simple main effects models to more complex specifications including: (1) fixed effects for group, sex, and brain region with significant two-way and three-way interactions; (2) random intercepts for participants (1|eegid), participant-region interactions (1|eegid:region), and random intercepts for nodes nesting in region (1|region:node). Post hoc contrasts were conducted using estimated marginal means (emmeans) to evaluate main effects and interactions, with Benjamini-Hochberg corrections applied to control the false discovery rate across multiple pairwise comparisons within each effect. Primary hypotheses tested group differences in oscillatory burst properties, with secondary analyses examining sex differences and regional specificity. All analyses were performed using R statistical software. Statistical significance was set at α = 0.05, with appropriate corrections applied for multiple testing where applicable. Effects sizes were calculated with 95% confidence intervals using Cohen’s d for continuous outcomes (burst amplitude, burst period), and rate ratio (RR) for Poisson-distributed count data (burst count). Complete effect size calculation results reported in Supplementary Tables 4 and 5.

Clinical associations

Hierarchical linear regression models were used to identify significant relationships with clinical variables and cycle features while controlling for potential confounding variables. In contrast to the LME analyses which contained a large number of within-participant replicates, our regression models required averaging cycle features per participant, reducing data redundancy. Thereby, outliers were identified and removed when exceeding 3 standard deviations from the mean, resulting in the exclusion of one participant for burst amplitude analyses, one for burst count analyses, and two for period analyses. Models included interaction terms to test for sex differences (clinical measure ~ cycle feature * sex + visit age), with follow-up sex-stratified analyses. Models were fitted using ordinary least squares regression and conducted at whole-brain level. Model performance was evaluated using adjusted R-squared values, and effect sizes were calculated using Cohen’s f2. Statistical significance was assessed at p < 0.05. All analyses were conducted in R statistical software. Demographic variables included chronological age at visit and sex. Clinical assessments included cognitive measures (IQ deviation scores, Stanford-Binet Intelligence Scale, Woodcock-Johnson III achievement test), behavioral assessments (Social Communication Questionnaire [SCQ] total score, Anxiety, Depression, and Mood Scale [ADAMS] subscales for mania, depression, social avoidance, anxiety, and obsessive-compulsive behaviors), and autism-related behaviors (Aberrant Behavior Checklist-Fragile X Syndrome [ABC-FXS] subscales for irritability, lethargy, stereotypy, hyperactivity, speech, and social avoidance).

Results

In this study, we utilized a previously published resting-state EEG dataset from our laboratory16, comparing source-localized recordings between 70 participants with a FXS diagnosis and 71 age- and sex-matched typically developing controls (TDC) (Fig. 2, Table 1). Neuropsychiatric assessments were used to estimate clinical phenotypic differences between groups. Raw data were blindly preprocessed, myogenic contamination and other artifacts were removed, and the data was filtered to isolate the alpha frequency band (8–12.5 Hz).

Fig. 2. Overview of methodology.

Fig. 2.

The analytical pipeline consists of four sequential stages. (1) EEG Data Acquisition: 128-channel resting-state EEG recordings undergo blinded preprocessing including filtering, artifact removal, and channel interpolation. (2) Source Localization: Weighted minimum norm estimation (MNE) reconstructs cortical activity, with 15,000 vertices parcellated into 68 Desikan-Killiany atlas nodes and grouped into 14 bilateral cortical regions65. (3) Cycle-by-Cycle Analysis: Alpha-band filtered signals (8–12.5 Hz) undergo burst detection using optimized bycycle parameters to identify sustained oscillatory activity on a cycle-by-cycle basis. (4) Burst Feature Characterization: Three key waveform features are extracted from detected bursts: burst count (binary occurrence), burst period (cycle duration), and burst amplitude (peak-to-trough magnitude).

Cycle-by-cycle waveform analysis was performed using the bycycle package to identify three alpha burst features of interest: burst count, period, and amplitude37. These features were analyzed by generalized linear mixed-effects models that included group (FXS or TDC), region (left and right; occipital, cingulate, parietal, temporal, central, frontal, and prefrontal), and sometimes sex (male or female) as fixed effects, with subject and nested node structure as random effects. To examine whether cycle-by-cycle alpha features might relate to behavioral and cognitive functioning, we conducted exploratory analyses testing associations between burst characteristics and clinical measures within the FXS group.

Reduced alpha burst count in FXS

Alpha bursts occurred significantly less frequently in FXS participants compared to controls, with an 11% reduction in burst count (TDC/FXS = 1.11, z = 3.19, P = 0.001, n = 141) (Fig. 3a,b). The reduction in alpha burst count showed sex-specific patterns. Males with FXS showed 19% fewer bursts than control males (TDC/FXS = 1.19, z = 4.07, P = 4.63 × 10−5, n = 79), whereas females with FXS and control females did not differ (TDC/FXS = 1.03, z = 0.65, P = 0.518, n = 62) (Fig. 3c,d).

Fig. 3. Burst features reveal dysrhythmic alpha burst activity in FXS.

Fig. 3.

(a) Group-level comparisons reveal significant differences across all three alpha burst features. FXS participants show reduced burst count (TDC/FXS = 1.11, z = 3.19, P = 0.001, n = 141), prolonged periods indicating slower frequencies (2.92 ms difference; t9556 = −4.86, P = 1.20 × 10−6), and elevated amplitudes (0.13 log10pA-m difference; t9555 = −6.23, P = 4.92 × 10−10) compared to TDC. (b) Subject-level rankings for each burst feature demonstrate the distribution of individual participants along the feature continuum. Bars are color-coded by group (FXS: dark red; TDC: gray). (c) Sex-stratified analysis with individual participant data points overlaid on boxplots demonstrates that burst count reductions are driven primarily by FXS males (TDC/FXS = 1.19, z = 4.07, P = 4.63 × 10−5, n = 79), while FXS females show no significant difference from TDC females (TDC/FXS = 1.03, z = 0.65, P = 0.518, n = 62). Period prolongation occurs in both FXS sexes, and amplitude elevation shows a main effect of sex with males > females across both groups (0.10 log10pA-m; t9555 = 5.00, P = 5.94 × 10−7). (d) Representative alpha-filtered raw time series signals from each group-sex combination showing cycle-by-cycle burst detection across three features: burst count (left), period (middle), and amplitude (right). Bold highlighting and associated filled dots above indicate identified bursts, horizontal bars indicate example burst periods, and vertical bars indicate example burst amplitudes. **P < 0.01; ***P < 0.001.

Parietal region reductions.

Regionally, alpha burst count was significantly reduced in FXS compared to TDC participants, and widespread across most cortical regions (Fig. 4a). The largest reductions were observed in the posterior association regions, notably the parietal cortices bilaterally (RP: TDC/FXS = 1.19, z = 4.38, P = 1.68 × 10−4, n = 141; LP: TDC/FXS = 1.16, z = 3.92, P = 6.18 × 10−4, n = 141) (Fig. 4d and Supplementary Table 2). The frontal and prefrontal cortices were the only regions not significantly different between FXS and TDC groups (Fig. 4d and Supplementary Table 2).

Fig. 4. Alpha burst abnormalities demonstrate distinct patterns across cortical areas.

Fig. 4.

(a) Group × region × sex interaction for burst count demonstrates that FXS males (red) show widespread reductions in burst occurrence compared to TDC males (blue) across most cortical regions, while FXS females (orange) show no significant differences from TDC females (purple). (b) Group × region analysis for burst period reveals prolonged alpha cycles in FXS compared to TDC, with the largest differences observed in central and cingulate regions. (c) Amplitude analysis shows elevated alpha burst strength in FXS, with particularly pronounced increases in temporal and sensory regions. Regions are arranged from sensory (left) to cognitive control areas (right). Regions shown as two-letter abbreviations from DK cortical atlas (Supplementary Table 3)65. Values on the y-axes are estimated marginal means (emmeans). Error bars represent 95% confidence intervals around the estimated marginal means. (d-f) Cortical surface maps based on the DK cortical atlas64 (Supplementary Fig. 1) display statistical contrasts (t-values) for TDC - FXS (negative values (red) indicate FXS > TDC; positive vales (blue) indicate TDC > FXS). Black outlines indicate regions with significant group differences (P < 0.05). (d) Burst count reductions (blue regions) are most prominent in parietal cortices (RP: TDC/FXS = 1.19, z = 4.38, P = 1.68 × 10−4, n = 141; LP: TDC/FXS = 1.16, z = 3.92, P = 6.18 × 10−4, n = 141). (e) Period prolongation (red regions) shows strongest effects in cingulate and central areas: left cingulate (LL: 4.6 ms; t9556 = −6.74, P = 1.52 × 10−10), right cingulate (RL: 4.5 ms; t9556 = −6.64, P = 1.52 × 10−10), left central (LC: 4.6 ms; t9556 = −6.65, P = 1.52 × 10−10), and right central (RC: 3.8 ms; t9556 = −5.41, P = 1.78 × 10−7). (f) Burst amplitude elevation in FXS (red regions) is most pronounced in sensory cortices: right temporal (RT: 0.17 log10pA-m; t9555 = −7.04, P = 2.78 × 10−11), left temporal (LT: 0.17 log10pA-m; t9555 = −6.88, P = 3.06 × 10−11), right occipital (RO: 0.17 log10pA-m; t9555 = −6.83, P = 3.15 × 10−11), and left occipital (LO: 0.17 log10pA-m; t9555 = −6.88, P = 3.06 × 10−11).

Positive age association.

Whole-brain alpha burst count showed a significant positive correlation with age (adjusted R2 = 0.130, f2 = 0.150, P = 0.023, n = 69), with this relationship being significant in females (adjusted R2 = 0.138, f2 = 0.161, P = 0.022, n = 31) but only trending in males (adjusted R2 = 0.054, f2 = 0.057, P = 0.087, n = 38), suggesting sex-specific developmental changes in alpha burst frequency across the lifespan in FXS (Fig. 5e,f).

Fig. 5. Alpha burst amplitude scales with hyperactivity and cognitive impairment in FXS.

Fig. 5.

The top row shows interaction models examining sex differences in the relationships between neural oscillation parameters and clinical outcomes. The bottom row displays the same relationships stratified by sex (orange = female, red = male). (a-b) Higher alpha burst amplitude was associated with greater hyperactivity scores on the ABC-FXS scale (adj R2 = 0.431, f2 = 0.756, P = 0.029, n = 62), with this relationship driven primarily by females (adj R2 = 0.285, f2 = 0.399, P = 0.008, n = 28) compared to males (adj R2 = 0.335, f2 = 0.505, P = 0.088, n = 34). (c-d) Lower nonverbal IQ scores showed a trending association with higher burst amplitude (adj R2 = 0.393, f2 = 0.649, P = 0.051, n = 63), with no significant sex interaction (P = 0.281). When analyzed separately by sex, neither males (adj R2 = 0.183, f2 = 0.225, P = 0.495, n = 32) nor females (adj R2 = 0.079, f2 = 0.086, P = 0.111, n = 31) showed significant associations. (e-f) Alpha burst count was positively associated with age (adj R2 = 0.130, f2 = 0.150, P = 0.023, n = 69), with no significant sex interaction (P = 0.786). This relationship was significant in females (adj R2 = 0.138, f2 = 0.161, P = 0.022, n = 31) but only marginal in males (adj R2 = 0.054, f2 = 0.057, P = 0.087, n = 38). All models controlled for age except the burst count-age relationship, which controlled for sex. Gray ribbons and shaded areas represent 95% confidence intervals. Points represent individual participants with residual values after controlling for covariates.

Increased alpha burst period in FXS

When alpha bursts did occur, burst periods were significantly prolonged by approximately 3 ms in the FXS group (t9556 = −4.86, P = 1.20 × 10−6) (Fig. 3a,b), and there were no sex effects or group by sex interactions observed (Fig. 3c,d).

Regional gradients in prolongation.

Alpha burst period was significantly longer in FXS across most cortical regions, with the strongest effects in cingulate and central cortices bilaterally, showing an approximate 4 ms prolongation: left cingulate (LL: 4.6 ms; t9556 = −6.74, P = 1.52 × 10−10), right cingulate (RL: 4.5 ms; t9556 = −6.64, P = 1.52 × 10−10), left central (LC: 4.6 ms; t9556 = 6.65, P = 1.52 × 10−10), and right central (RC: 3.8 ms; t9556 = −5.41, P = 1.78 × 10−7) (Fig. 4b,e and Supplementary Table 2). In contrast, this prolongation diminished progressively toward sensory cortices, where occipital and temporal regions showed substantially smaller period changes: right occipital (RO: 1.3 ms; t9556 = −1.88, P = 0.060), left occipital (LO: 1.4 ms; t9556 = 1.99, P = 0.050), right temporal (RT: 1.6 ms; t9556 = −2.49, P = 0.016), and left temporal (LT: 1.6 ms; t9556 = −2.46, P = 0.016) (Fig. 4b,e and Supplementary Table 2).

No clinical associations.

Whole-brain burst period was not significantly associated with any clinical measures.

Elevated alpha burst amplitudes in FXS

Burst amplitudes were elevated in FXS (0.13 log10pA-m difference; t9555 = −6.23, P = 4.92 × 10−10), indicating stronger individual oscillatory pulses (Fig. 3a,b). A main effect of sex was observed, with males showing higher alpha burst amplitude than females overall (0.10 log10pA-m; t9555 = 5.00, P = 5.94 × 10−7), and both FXS males and females exhibited elevated amplitudes relative to their sex-matched controls (Fig. 3c,d). There was no group by sex interaction detected.

Sensory region elevations.

While alpha burst amplitude was significantly elevated in FXS across all cortical regions (Fig. 4c,f), there were particularly strong increases in sensory-oriented regions, including temporal and occipital cortices bilaterally: right temporal (RT: 0.17 log10pA-m; t9555 = −7.04, P = 2.78 × 10−11), left temporal (LT: 0.17 log10pA-m; t9555 = −6.88, P = 3.06 × 10−11), right occipital (RO: 0.17 log10pA-m; t9555 = −6.83, P = 3.15 × 10−11), and left occipital (LO: 0.17 log10pA-m; t9555 = −6.88, P = 3.06 × 10−11) (Fig. 4c,f and Supplementary Table 2), precisely where period prolongation was minimal. Central regions, which showed especially increased burst period, exhibited the smallest amplitude elevations (LC: 0.071 log10pA-m; t9555 = −2.78, P = 0.005; RC: 0.089 log10pA-m; t9555 = −3.51, P = 4.92 × 10−4) (Fig. 4c,f and Supplementary Table 2).

Positive hyperactivity association.

Higher whole-brain burst amplitudes were significantly associated with increased hyperactivity scores (adjusted R2 = 0.431, f2 = 0.756, P = 0.029, n = 62), with this relationship being particularly pronounced in females (adjusted R2 = 0.285, f2 = 0.399, P = 0.008, n = 28) compared to males (adjusted R2 = 0.335, f2 = 0.505, p = 0.088, n = 34) (Fig. 5a,b). Burst amplitude showed a trending negative association with general intelligence (NVIQ) scores (adjusted R2 = 0.393, f2 = 0.649, P = 0.051, n = 63), indicating that higher amplitude bursts may correspond to poorer cognitive performance, though sex-stratified analyses revealed no significant associations in either males or females (Fig. 5c,d).

Cross-feature spatial dissociation of burst abnormalities across cortical regions

Alpha bursts in FXS are characterized by fewer but stronger and slower oscillatory events that do not affect all cortical regions uniformly. Regions exhibiting the strongest prolongation (increased burst period), notably cingulate and central cortices, showed minimal amplitude elevations, whereas sensory cortices, temporal and occipital, displaying the largest amplitude increases demonstrated less time-related change (Fig. 4). Burst count reductions aligned most closely with regions showing prolonged period rather than elevated amplitude. Therefore, regions characterized by complex inter-regional connectivity showed predominant time-associated dysregulation, whereas primarily sensory cortices showed amplitude-dominant patterns, potentially reflecting distinct circuit-level properties.

Discussion

Deviations in alpha oscillatory power are frequently cited across various neuropsychiatric conditions from Parkinson’s disease to ASD8, 10, however, this lack of specificity has also limited its utility as a biomarker. Alpha oscillations’ central role in coordinating cortical networks and their vulnerability across neuropathologies48, 49 suggests that more mechanistic characteristics of alpha dynamics beyond aggregate power may hold promise as prognostic or therapeutic markers. Conventional power spectral analysis collapses time and, in relative metrics, normalizes by total broadband activity, thereby obscuring burst structure and permitting the coexistence of higher absolute yet lower relative alpha power.

FXS, an X-linked monogenic disorder, is associated with pronounced and replicable sex-specific alterations in alpha spectral profiles among neurodevelopmental conditions16, 18, 50. FXS arises from a near-complete loss of a single protein (FMRP) with well-characterized disruption of synaptic and circuit function21, 23, 24. It therefore represents a critical model for testing whether mechanistic features of alpha dynamics can be linked to clinical phenotypes and predictions of circuit level dysfunction. We conducted a discontinuous cycle-by-cycle burst analysis, decomposing aggregate power into distinct burst features, providing more specific targets. This approach revealed that alpha activity in FXS is not simply stronger or weaker, but fundamentally dysrhythmic.

We found that FXS is characterized by alpha bursts that have (1) reduced burst count specifically in males, (2) prolonged burst periods across both sexes, (3) increased burst amplitudes in both sexes, with males showing the most pronounced increases, and (4) spatially dissociated patterns, with burst count and burst period alterations greatest in posterior-parietal and midline-central regions, while burst amplitude increases were maximal in sensory cortices. These findings delineate the time-associated structure of alpha dysregulation in FXS, identifying burst-level signatures that enable hypothesis generation about thalamocortical and interneuron mechanisms and their potential as translational biomarkers.

Dysrhythmic alpha burst dynamics address paradoxical power findings

Alpha bursts in FXS are less frequent, slower, yet higher amplitude relative to controls, as reflected by decreased burst count, prolonged burst periods, and increased burst amplitude. Since spectral power scales with the square of amplitude, increased burst amplitude can disproportionately elevate absolute alpha power51. When paired with reduced burst count and longer burst period, the time-related density of alpha activity is decreased, yielding a lower relative power when normalized by total broadband activity, consistent with our previous work16. Bycycle quantifies burst-level timing and morphology in the time domain; while burst amplitude contributes to absolute power, this method captures time-related density and waveform shape that are not represented by absolute or relative power estimates. Furthermore, this burst-level analytic framework may be applicable to other neurodevelopmental and neuropsychiatric disorders characterized by oscillatory dysrhythmias, enabling cross-condition comparisons and refining circuit-level biomarkers.

Alpha burst features demonstrate complex sex effects

Sex-specific patterns in alpha oscillatory dysfunction appear to align with established phenotypic differences between males and females with FXS25. The reduction in alpha burst count was driven entirely by males, with FXS females showing burst counts statistically indistinguishable from control females. This preservation may suggest that FMRP expression from random X-inactivation in females is sufficient to maintain burst generation. Burst amplitude showed elevations in both FXS males and females compared to same-sex controls, with FXS males exhibiting the highest values overall. This pattern likely reflects both FMRP-dependent processes as well as baseline sex differences, as even TDC males had higher burst amplitudes than TDC females. Alpha period prolongation occurred across both sexes in the FXS group, representing a fundamental aspect of FXS pathophysiology, as even millisecond-scale period shifts can potentially disrupt spike-timing precision and cross-regional phase coherence20, 52. These mechanistic deviations likely contribute to impaired temporal coordination of neural activity, which has been directly linked to core behavioral deficits in FXS, including sensory hypersensitivity, attention instability, and social-communication impairments16, 53–55. This finding of sex-independent period prolongation in FXS has important implications for biomarker development. While previous FXS research has focused predominantly on males due to their more severe phenotypic presentation56, alpha period provides a quantifiable neural signature that is equally detectable in both sexes, enabling more inclusive approaches to future clinical trials and mechanistic studies.

Dissociable alpha rhythms: gradient regional specificity informs mechanisms

Our regional analysis reveals that while alpha dysregulation occurs mostly globally in FXS, distinct properties of the alpha rhythm show their strongest effects in specific cortical areas, suggesting spatially dissociable alpha dysfunction. Timing-associated dysregulation, prolonged periods and reduced burst counts, was most pronounced in posterior association cortices (parietal) and cognitive control regions (central, cingulate), areas serving as hubs within attentional and executive networks57. In contrast, amplitude elevations were strongest in sensory cortices (occipital, temporal), regions where alpha is thought to gate sensory processing through inhibitory mechanisms58. This graded pattern of regional differences suggests that the widespread oscillatory dysfunction in FXS, stemming from the absence of FMRP, interacts with the unique functional demands and circuit properties of different brain regions. This spatial dissociation may further reflect differential vulnerability of alpha generation mechanisms across the cortical hierarchy. Cortical regions generate alpha oscillations that propagate across cortical areas in hierarchical patterns from higher-order to lower-order regions6. Our findings suggest that the timing-related dominant patterns in higher-order regions may reflect disrupted network-level coordination, and the amplitude-dominant patterns in lower-order sensory cortices may reflect local circuit properties of potentially enhanced pyramidal neuron synchrony. Critically, these patterns emerged from resting-state recordings without task demands, indicating they reflect intrinsic circuit dysfunction rather than state-dependent engagement.

Alpha burst characteristics associated with clinical measures in FXS

The present exploratory findings reveal complex relationships between alpha burst characteristics and clinical phenotypes in FXS, with notable sex-specific patterns. While our previous work demonstrated that reduced relative alpha power correlated with anxiety, auditory attention, and social functioning deficits16, burst amplitude emerged as the most clinically relevant feature, showing significant associations with hyperactivity behaviors and trending associations with general intelligence. This divergence suggests that different aspects of alpha dynamics, aggregate relative spectral power compared to burst-level characteristics, may relate to distinct symptom domains in FXS. Hyperactivity is an established characteristic of FXS, notable in both humans and associated Fmr1 KO mice25, 59. The relationship with hyperactivity was particularly pronounced in females, suggesting possible sex-dependent neural mechanisms underlying behavioral regulation in FXS. The association between higher burst amplitudes and lower generalized IQ, while not reaching conventional significance, suggests potential relationships between oscillatory strength and cognitive performance that warrant further investigation. The developmental trajectory of burst count, showing positive associations with age particularly in females, aligns with previous findings of increased PAF with development60, 61, potentially indicating that alpha burst generation may reflect maturational processes. These findings position alpha burst amplitude as a potentially valuable neurobiological marker that scales with core behavioral phenotypes, though the mechanisms underlying these relationships require further investigation.

Interneuron circuit dysfunction as unifying mechanism

The distinct cycle-by-cycle features of alpha dysregulation in FXS, reduced burst count, prolonged periods, and increased amplitudes, are consistent with interneuron circuit dysfunction, particularly involving parvalbumin (PV) and somatostatin (SOM) expressing GABAergic interneurons. Recent computational work by Tahvili et al. demonstrates that PV and SOM interneurons play distinct causal roles in controlling network oscillations, with SOM cells primarily modulating oscillation amplitude while PV cells regulate frequency and network stability62. The CAMINOS (canonical microcircuit network oscillations) model reveals that increasing SOM-to-PV ratios produces oscillatory dynamics at lower frequencies, transitioning from gamma frequencies toward slower alpha/beta oscillations.

There is a well-established reduction of neocortical PV+ interneurons in FXS63, 64. Evidence for SOM interneuron alterations is relatively unexplored in FXS, although a preservation of SOM density has been reported65. However, prolonged loss of PV cells may trigger increased SOM interneuron activity to compensate for altered excitation-inhibition balance, representing homeostatic circuit stabilization66, 67. If PV interneurons are reduced while SOM interneurons are relatively preserved or increased, the effective SOM/PV ratio would increase. Based on the computational framework, this altered ratio could explain our key findings: decreased PV function may account for prolonged cycle periods and reduced burst occurrence (reflecting decreased frequencies and network stability), while relatively increased SOM influence could explain the increased amplitudes observed across both sexes (Fig. 6).

Fig. 6. Model of hypothesized interneuron circuit dysfunction underlying alpha oscillation dysregulation in FXS.

Fig. 6.

(a) Simulated alpha oscillations (grey) demonstrate how increasing SOM/PV interneuron ratios (left to right) reproduce the characteristic transition from TDC to FXS oscillatory patterns. Black regions indicate alpha bursts. Orange circles represent PV interneurons, which decrease in density from left to right. Blue circles represent SOM interneurons, with SOM/PV ratios progressively increasing. As the SOM/PV ratio increases, alpha oscillations exhibit the hallmark FXS features: reduced burst frequency, prolonged burst periods, and increased burst amplitudes. This computational framework suggests that PV interneuron loss combined with relative SOM interneuron preservation drives the distinct cycle-by-cycle alpha dysregulation observed in FXS, with reduced PV function accounting for decreased network stability and prolonged periods, while increased SOM influence contributes to enhanced oscillation amplitudes. (b) Average waveforms of alpha bursts for each group: FXS males (red), FXS females (orange), TDC males (blue), and TDC females (purple). Waveforms aligned by the first trough (time at 0) and axes limited to emphasize first cycle differences (0–150 ms). Vertical dashed lines indicate period of the first cycle within the burst. (c) Ranked bar plot showing average alpha band burst amplitudes for individual subjects, ordered from lowest to highest amplitude. Each bar represents one subject’s mean burst amplitude with colors indicating group membership: FXS males (red), TDC males (blue), FXS females (orange), and TDC females (purple). Analysis excludes one outlier subject (241) with amplitude exceeding 3 standard deviations above the group mean.

Cross-species translation and mechanistic validation

A critical next step involves validating these findings in Fmr1 KO mouse models to address whether the observed alpha burst feature alterations represent compensatory mechanisms or primary pathological processes. While translational studies have established consistent gamma abnormalities across species, alpha oscillations present a more complex picture. Resting-state studies in Fmr1 KO mice show conflicting results, with some demonstrating reduced relative alpha power similar to human FXS while others show no differences from controls31, 32. Future studies should apply cycle-by-cycle analysis to resting-state recordings in Fmr1 KO mice to determine whether the specific burst characteristics we identified are conserved across species. Further, this bycycle approach will allow us to explore the conflicting results surrounding alpha power in Fmr1 KO mice, investigating the contributions of reduced alpha burst count and increased burst amplitude that may be concealing differences in alpha power. Crucially, these studies should incorporate quantification of SOM/PV interneuron ratios across brain regions through immunohistochemistry or optogenetic approaches, enabling direct testing of our proposed mechanistic framework. Selective silencing or activation of PV versus SOM interneuron populations could establish causal relationships between altered interneuron balance and specific cycle-by-cycle features, addressing the fundamental question of whether these oscillatory changes drive clinical symptoms or represent compensatory responses.

Biomarker potential and therapeutic applications

Our cycle-by-cycle alpha features represent valuable biomarkers with immediate therapeutic potential. The quantifiable nature of burst count, period, and amplitude provides objective metrics that could enhance sensitivity in clinical trials, better stratify patient groups, and guide treatment development. For BCI applications, real-time detection of these aberrant alpha dynamics could trigger targeted neuromodulation to restore healthy oscillatory patterns68. The correlation between alpha amplitude and symptom severity suggests these metrics could serve as both treatment targets and outcome measures, providing a neurobiologically-grounded approach to monitoring therapeutic progress that complements traditional behavioral assessments.

Limitations

Since our data was collected during resting-state, to test hypotheses related to how alpha dysfunction in FXS relates to region-specific function, future studies will need to explore how alpha burst features are modulated during cognitive and sensory task-based paradigms. For example, we would predict that during auditory stimulation, burst amplitude specifically will increase in the temporal regions. Further, this study is limited by its cross-sectional design, which precludes assessment of longitudinal changes in alpha burst dynamics. Additionally, while the effect of non-epileptic medications on our results cannot be disregarded, previous EEG studies in neuropsychiatric conditions have shown minimal associations with medication variables69, including in FXS53. Further, while source localization remains limited by the inverse problem, it is currently the best method to achieve cortical spatial resolution40 in populations with sensory hypersensitivities such as in FXS, where MRI-based methods are often not feasible. From a methodological perspective, no single cycle feature fully characterizes waveform physiology, so our focus on three specific metrics (burst count, period, and amplitude) may not capture all relevant aspects of oscillatory dysfunction37. These features were selected to disambiguate the paradoxical alpha power findings, but additional analyses looking at state transition dynamics or within-burst feature modulation may reveal a more complete picture of alpha dysregulation in FXS. This study is a post hoc analysis, so such exploratory findings would benefit from replication in future cohorts. Lastly, FMRP expression was not quantified for participants, limiting potential stratification by molecular severity as it may contribute to withingroup variability.

Conclusions

This cycle-by-cycle analysis reveals that FXS is characterized by complex alpha oscillatory dysfunction that extends beyond simple power reductions to encompass fundamental alterations in burst dynamics and temporal structure. While alpha oscillations remain one of the most robust yet mechanistically underspecified signals in clinical neuroscience, this work demonstrates that moving beyond aggregate power to cycle-by-cycle burst features reveals disorder-specific, sexually dimorphic, and regionally selective signatures that traditional spectral approaches obscure. These findings demonstrate that different dimensions of alpha physiology (burst count, period, and amplitude) may fractionate along distinct symptom domains and disorders, offering a path toward objective, mechanistically grounded biomarkers. Alpha dysregulation represents a final common pathway whose precise parameterization may ultimately guide circuit-based stratification and individualized therapeutic strategies across neurodevelopmental and neuropsychiatric disorders.

Acknowledgements

We thank the participants and families involved at the Cincinnati Fragile X Research and Treatment Center who participated in this study.

Funding

The study was federally funded by the National Institutes of Health (NIH) (U54HD028008 and U54HD104461).

Abbreviations

ABC

Aberrant Behavior Checklist

ADAMS

Anxiety, Depression, and Mood Scale

DK

Desikan-Killiany (atlas)

EEG

electroencephalography

EGI

Electrical Geodesics, Inc.

FMRP

fragile X messenger ribonucleoprotein

FXS

Fragile X syndrome

GLMM

generalized linear mixed-effects models

IQ

intelligence quotient

KO

knockout

LC

Left Central

LF

Left Frontal

LL

Left Cingulate

LO

Left Occipital

LP

Left Parietal

LPF

Left Prefrontal

LT

Left Temporal

MNE

minimum norm estimate

MRI

magnetic resonance imaging

NVIQ

nonverbal intelligence quotient

PAF

peak alpha frequency

PV

parvalbumin

RC

Right Central

RF

Right Frontal

RL

Right Cingulate

RO

Right Occipital

RP

Right Parietal

RPF

Right Prefrontal

RT

Right Temporal

SCQ

Social Communication Questionnaire

SOM

somatostatin

TDC

typically developing controls

Funding Statement

The study was federally funded by the National Institutes of Health (NIH) (U54HD028008 and U54HD104461).

Footnotes

Ethics approval and consent to participate

All procedures were conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent (or assent, where applicable), and the study was approved by the institutional review board of Cincinnati Children’s Hospital Medical Center.

Competing interests

The authors declare no competing interests.

Availability of data and materials

The de-identified datasets and code used for analysis in this study are available from the corresponding author upon request. EEG datasets are available at https://doi.org/10.5281/zenodo.6385768. Correspondence and material requests should be addressed to Peyton Siekierski.

References

  • 1.Lopes Da Silva FH, Storm Van Leeuwen W. The cortical source of the alpha rhythm. Neurosci Lett. 1977. Nov;6(2–3):237–41. [DOI] [PubMed] [Google Scholar]
  • 2.Strauss A, Wostmann M, Obleser J. Cortical alpha oscillations as a tool for auditory selective inhibition. Front Hum Neurosci. 2014;8:350. Epub 20140528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Goldman RI, Stern JM, Engel J Jr., Cohen MS. Simultaneous EEG and fMRI of the alpha rhythm. Neuroreport. 2002. Dec 20;13(18):2487–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhang H, Watrous AJ, Patel A, Jacobs J. Theta and Alpha Oscillations Are Traveling Waves in the Human Neocortex. Neuron. 2018. Jun 27;98(6):1269–81 e4. Epub 20180607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Clayton MS, Yeung N, Cohen Kadosh R. The many characters of visual alpha oscillations. Eur J Neurosci. 2018. Oct;48(7):2498–508. Epub 20171106. [DOI] [PubMed] [Google Scholar]
  • 6.Halgren M, Ulbert I, Bastuji H, Fabo D, Eross L, Rey M, et al. The generation and propagation of the human alpha rhythm. Proc Natl Acad Sci U S A. 2019. Nov 19;116(47):23772–82. Epub 20191104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bastiaens SP, Momi D, Griffiths JD. A comprehensive investigation of intracortical and corticothalamic models of the alpha rhythm. PLoS Comput Biol. 2025. Apr;21(4):e1012926. Epub 20250410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dickinson A, DiStefano C, Senturk D, Jeste SS. Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur J Neurosci. 2018. Mar;47(6):643–51. Epub 20170801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Murphy M, Ongur D. Decreased peak alpha frequency and impaired visual evoked potentials in first episode psychosis. Neuroimage Clin. 2019;22:101693. Epub 20190221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zhao Y, Cai J, Song J, Shi H, Kong W, Li X, et al. Peak alpha frequency and alpha power spectral density as vulnerability markers of cognitive impairment in Parkinson’s disease: an exploratory EEG study. Front Neurosci. 2025;19:1575815. Epub 20250429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ippolito G, Bertaccini R, Tarasi L, Di Gregorio F, Trajkovic J, Battaglia S, et al. The Role of Alpha Oscillations among the Main Neuropsychiatric Disorders in the Adult and Developing Human Brain: Evidence from the Last 10 Years of Research. Biomedicines. 2022. Dec 8;10(12). Epub 20221208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Trajkovic J, Di Gregorio F, Ferri F, Marzi C, Diciotti S, Romei V. Resting state alpha oscillatory activity is a valid and reliable marker of schizotypy. Sci Rep. 2021. May 17;11(1):10379. Epub 20210517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Choi S, Yu E, Lee S, Llinas RR. Altered thalamocortical rhythmicity and connectivity in mice lacking CaV3.1 T-type Ca2+ channels in unconsciousness. Proc Natl Acad Sci U S A. 2015. Jun 23;112(25):7839–44. Epub 20150608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Llinas R, Urbano FJ, Leznik E, Ramirez RR, van Marle HJ. Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect. Trends Neurosci. 2005. Jun;28(6):325–33. [DOI] [PubMed] [Google Scholar]
  • 15.Llinas RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci U S A. 1999. Dec 21;96(26):15222–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pedapati EV, Schmitt LM, Ethridge LE, Miyakoshi M, Sweeney JA, Liu R, et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Commun Biol. 2022. 2022/05/11/;5(1):442. en. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wilkinson CL, Nelson CA. Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability. Molecular Autism. 2021. 2021/02/25/;12(1):17. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodev Disord. 2017;9:11. Epub 20170314. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.van der Molen MJ, Stam CJ, van der Molen MW. Resting-state EEG oscillatory dynamics in fragile X syndrome: abnormal functional connectivity and brain network organization. PLOS ONE. 2014;9(2):e88451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Klimesch W, Sauseng P, Hanslmayr S. EEG alpha oscillations: the inhibition-timing hypothesis. Brain Res Rev. 2007. Jan;53(1):63–88. Epub 20140211. [DOI] [PubMed] [Google Scholar]
  • 21.Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992. Sep;1(6):397–400. [DOI] [PubMed] [Google Scholar]
  • 22.Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet. 2001. Feb 15;10(4):329–38. [DOI] [PubMed] [Google Scholar]
  • 23.Tessier CR, Broadie K. Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning. Development. 2008. Apr;135(8):1547–57. Epub 20080305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gross C, Yao X, Pong DL, Jeromin A, Bassell GJ. Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. J Neurosci. 2011. Apr 13;31(15):5693–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB Jr., Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Primers. 2017. Sep 29;3:17065. Epub 20170929. [DOI] [PubMed] [Google Scholar]
  • 26.Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, et al. Fragile X targeted pharmacotherapy: lessons learned and future directions. J Neurodev Disord. 2017;9:7. Epub 20170612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, et al. Best Practices in Fragile X Syndrome Treatment Development. Brain Sci. 2018. Dec 15;8(12). Epub 20181215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Neul JL. Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research. J Clin Invest. 2024. Mar 1;134(5). Epub 20240301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sahin M, Jones SR, Sweeney JA, Berry-Kravis E, Connors BW, Ewen JB, et al. Discovering translational biomarkers in neurodevelopmental disorders. Nat Rev Drug Discov. 2018. Dec 20. Epub 20181220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Norris JE, DeStefano LA, Schmitt LM, Pedapati EV, Erickson CA, Sweeney JA, et al. Hemispheric Utilization of Alpha Oscillatory Dynamics as a Unique Biomarker of Neural Compensation in Females with Fragile X Syndrome. ACS Chem Neurosci. 2022. Dec 7;13(23):3389–402. Epub 20221121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kozono N, Okamura A, Honda S, Matsumoto M, Mihara T. Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome. Sci Rep. 2020. Nov 2;10(1):18799. Epub 20201102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jonak CR, Assad SA, Garcia TA, Sandhu MS, Rumschlag JA, Razak KA, et al. Phenotypic analysis of multielectrode array EEG biomarkers in developing and adult male Fmr1 KO mice. Neurobiology of Disease. 2024. 2024/06/01/;195:106496. [DOI] [PubMed] [Google Scholar]
  • 33.Kornfeld-Sylla SS, Gelegen C, Norris JE, Chaloner FA, Lee M, Khela M, et al. A human electrophysiological biomarker of Fragile X Syndrome is shared in V1 of Fmr1 KO mice and caused by loss of FMRP in cortical excitatory neurons. bioRxiv. 2025. Mar 19. Epub 20250319. [Google Scholar]
  • 34.Cole SR, Voytek B. Brain Oscillations and the Importance of Waveform Shape. Trends Cogn Sci. 2017. Feb;21(2):137–49. Epub 20170104. [DOI] [PubMed] [Google Scholar]
  • 35.Jones SR. When brain rhythms aren’t ‘rhythmic’: implication for their mechanisms and meaning. Current Opinion in Neurobiology. 2016. 2016/10/01/;40:72–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bollimunta A, Chen Y, Schroeder CE, Ding M. Neuronal mechanisms of cortical alpha oscillations in awake-behaving macaques. J Neurosci. 2008. Oct 1;28(40):9976–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cole S, Voytek B. Cycle-by-cycle analysis of neural oscillations. J Neurophysiol. 2019. Aug 1;122(2):849–61. Epub 20190703. [DOI] [PubMed] [Google Scholar]
  • 38.Erfianto B, Rizal A, Hadiyoso S. Empirical Mode Decomposition and Hilbert Spectrum for Abnormality Detection in Normal and Abnormal Walking Transitions. Int J Environ Res Public Health. 2023. Feb 22;20(5). Epub 20230222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shin H, Law R, Tsutsui S, Moore CI, Jones SR. The rate of transient beta frequency events predicts behavior across tasks and species. eLife. 2017. 2017/11/06/;6:e29086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Song J, Davey C, Poulsen C, Luu P, Turovets S, Anderson E, et al. EEG source localization: Sensor density and head surface coverage. J Neurosci Methods. 2015. Dec 30;256:9–21. Epub 20150820. [DOI] [PubMed] [Google Scholar]
  • 41.Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004. Mar 15;134(1):9–21. [DOI] [PubMed] [Google Scholar]
  • 42.Lee TW, Girolami M, Sejnowski TJ. Independent component analysis using an extended infomax algorithm for mixed subgaussian and supergaussian sources. Neural Comput. 1999. Feb 15;11(2):417–41. [DOI] [PubMed] [Google Scholar]
  • 43.Fitzgibbon SP, DeLosAngeles D, Lewis TW, Powers DM, Grummett TS, Whitham EM, et al. Automatic determination of EMG-contaminated components and validation of independent component analysis using EEG during pharmacologic paralysis. Clin Neurophysiol. 2016. Mar;127(3):1781–93. Epub 20151218. [DOI] [PubMed] [Google Scholar]
  • 44.Fonov V, Evans AC, Botteron K, Almli CR, McKinstry RC, Collins DL, et al. Unbiased average age-appropriate atlases for pediatric studies. Neuroimage. 2011. Jan 1;54(1):313–27. Epub 20100723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Tadel F, Baillet S, Mosher JC, Pantazis D, Leahy RM. Brainstorm: a user-friendly application for MEG/EEG analysis. Comput Intell Neurosci. 2011;2011:879716. Epub 20110413. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gramfort A, Papadopoulo T, Olivi E, Clerc M. OpenMEEG: opensource software for quasistatic bioelectromagnetics. Biomed Eng Online. 2010. Sep 06;9:45. Epub 20100906. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006. Jul 01;31(3):968–80. Epub 20060310. eng. [DOI] [PubMed] [Google Scholar]
  • 48.Gordon E, Palmer DM, Cooper N. EEG alpha asymmetry in schizophrenia, depression, PTSD, panic disorder, ADHD and conduct disorder. Clin EEG Neurosci. 2010. Oct;41(4):178–83. [DOI] [PubMed] [Google Scholar]
  • 49.Sadaghiani S, Kleinschmidt A. Brain Networks and alpha-Oscillations: Structural and Functional Foundations of Cognitive Control. Trends Cogn Sci. 2016. Nov;20(11):805–17. Epub 20161001. [DOI] [PubMed] [Google Scholar]
  • 50.Elmaghraby R, Liu Y, Ramesh P, Westerkamp G, Nelson MA, Larsh T, et al. Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome. Mol Autism. 2025. Oct 1;16(1):49. Epub 20251001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Quinn AJ, van Ede F, Brookes MJ, Heideman SG, Nowak M, Seedat ZA, et al. Unpacking Transient Event Dynamics in Electrophysiological Power Spectra. Brain Topogr. 2019. Nov;32(6):1020–34. Epub 20191121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gips B, van der Eerden JP, Jensen O. A biologically plausible mechanism for neuronal coding organized by the phase of alpha oscillations. Eur J Neurosci. 2016. Aug;44(4):2147–61. Epub 20160718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ethridge LE, De Stefano LA, Schmitt LM, Woodruff NE, Brown KL, Tran M, et al. Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance. Front Integr Neurosci. 2019;13:60. Epub 20191009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ethridge LE, White SP, Mosconi MW, Wang J, Pedapati EV, Erickson CA, et al. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome. Mol Autism. 2017;8:22. Epub 20170607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Pedapati EV, Ethridge LE, Liu Y, Liu R, Sweeney JA, DeStefano LA, et al. Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivity. PLOS ONE. 2025. 2025/05/20/;20(5):e0306157. en. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bartholomay KL, Lee CH, Bruno JL, Lightbody AA, Reiss AL. Closing the Gender Gap in Fragile X Syndrome: Review on Females with FXS and Preliminary Research Findings. Brain Sci. 2019. Jan 12;9(1). Epub 20190112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.van Oort J, Tendolkar I, Hermans EJ, Mulders PC, Beckmann CF, Schene AH, et al. How the brain connects in response to acute stress: A review at the human brain systems level. Neurosci Biobehav Rev. 2017. Dec;83:281–97. Epub 20171024. [DOI] [PubMed] [Google Scholar]
  • 58.Foxe JJ, Snyder AC. The Role of Alpha-Band Brain Oscillations as a Sensory Suppression Mechanism during Selective Attention. Front Psychol. 2011;2:154. Epub 20110705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ding Q, Sethna F, Wang H. Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background. Behav Brain Res. 2014. Sep 1;271:72–8. Epub 20140602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Freschl J, Azizi LA, Balboa L, Kaldy Z, Blaser E. The development of peak alpha frequency from infancy to adolescence and its role in visual temporal processing: A meta-analysis. Dev Cogn Neurosci. 2022. Oct;57:101146. Epub 20220809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Turner C, Baylan S, Bracco M, Cruz G, Hanzal S, Keime M, et al. Developmental changes in individual alpha frequency: Recording EEG data during public engagement events. Imaging Neurosci (Camb). 2023. Aug 1;1:1–14. Epub 20230810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Tahvili F, Vinck M, di Volo M. PV and SOM cells play distinct causal roles in controlling network oscillations and stability. Cell Rep. 2025. Aug 8;44(8):116131. Epub 20250808. [DOI] [PubMed] [Google Scholar]
  • 63.Selby L, Zhang C, Sun Q-Q. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neuroscience Letters. 2007. 2007/02/02/;412(3):227–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Juarez P, Salcedo-Arellano MJ, Dufour B, Martinez-Cerdeno V. Fragile X cortex is characterized by decreased parvalbumin-expressing interneurons. Cereb Cortex. 2024. Mar 1;34(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Paluszkiewicz SM, Olmos-Serrano JL, Corbin JG, Huntsman MM. Impaired inhibitory control of cortical synchronization in fragile X syndrome. J Neurophysiol. 2011. Nov;106(5):2264–72. Epub 20110727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Antoine MW, Langberg T, Schnepel P, Feldman DE. Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models. Neuron. 2019. Feb 20;101(4):648–61 e4. Epub 20190121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Lovelace JW, Rais M, Palacios AR, Shuai XS, Bishay S, Popa O, et al. Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome. Cereb Cortex. 2020. Mar 14;30(3):969–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Citarella J, Siekierski P, Ethridge L, Westerkamp G, Liu Y, Blank E, et al. FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions. Front Neurosci. 2025;19:1618804. Epub 20250909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, et al. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. Am J Psychiatry. 2016. Apr 1;173(4):373–84. Epub 20151207. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The de-identified datasets and code used for analysis in this study are available from the corresponding author upon request. EEG datasets are available at https://doi.org/10.5281/zenodo.6385768. Correspondence and material requests should be addressed to Peyton Siekierski.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES